Biyun Wang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 69
- Cancer Treatment and Pharmacology 32
- HER2/EGFR in Cancer Research 30
- Colorectal Cancer Treatments and Studies 9
- Lung Cancer Research Studies 6
-
- Advanced Breast Cancer Therapies 22
- Brain Metastases and Treatment 6
- Co-authors
- Xichun Hu (57 shared papers)Leiping Wang (55 shared papers)Jun Cao (40 shared papers)Jian Zhang (30 shared papers)Zhonghua Wang (18 shared papers)Ziang Yang (2 shared papers)Hong Wang (1 shared paper)Zhonghua Wang (15 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)BMC Cancer (8 papers)Oncotarget (7 papers)Therapeutic Advances in Medical Oncology (7 papers)Frontiers in Oncology (7 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Biyun Wang
143 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 108
- Cancer Research 487
- Oncology 870
- Otorhinolaryngology 115
- Pulmonary and Respiratory Medicine 566
- Pharmaceutical Science 94
Countries citing papers authored by Biyun Wang
This map shows the geographic impact of Biyun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biyun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biyun Wang more than expected).
Fields of papers citing papers by Biyun Wang
This network shows the impact of papers produced by Biyun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biyun Wang. The network helps show where Biyun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Biyun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 218 | |
| 2 | 2014 | 176 | |
| 3 | 2012 | 139 | |
| 4 | 2011 | 110 | |
| 5 | 2010 | 95 | |
| 6 | 2024 | 85 | |
| 7 | 2008 | 83 | |
| 8 | 2018 | 71 | |
| 9 | 2013 | 65 | |
| 10 | 2014 | 58 | |
| 11 | 2021 | 51 | |
| 12 | 2016 | 51 | |
| 13 | 2022 | 49 | |
| 14 | 2017 | 49 | |
| 15 | 2022 | 45 | |
| 16 | MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A. | 2015 | 44 |
| 17 | 2007 | 38 | |
| 18 | 2018 | 37 | |
| 19 | 2020 | 34 | |
| 20 | 2010 | 34 |
About Biyun Wang
Biyun Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 150 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (32 papers), HER2/EGFR in Cancer Research (30 papers), Advanced Breast Cancer Therapies (22 papers), Breast Cancer Treatment Studies (14 papers), Colorectal Cancer Treatments and Studies (9 papers), Medical Imaging Techniques and Applications (7 papers), Lung Cancer Research Studies (6 papers) and Brain Metastases and Treatment (6 papers). The work is most often cited by research in Cancer Research (487 citations), Oncology (870 citations), Otorhinolaryngology (115 citations), Pulmonary and Respiratory Medicine (566 citations) and Pharmaceutical Science (94 citations). Biyun Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xichun Hu, Leiping Wang, Jun Cao, Jian Zhang, Zhonghua Wang, Ziang Yang, Hong Wang, Zhonghua Wang, Zhimin Shao and Zhonghua Tao. Their work appears in journals such as Journal of Clinical Oncology, BMC Cancer, Oncotarget, Therapeutic Advances in Medical Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.